Last $62.71 USD
Change Today +0.30 / 0.48%
Volume 8.6M
MDT On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 8:04 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

710 Medtronic Parkway

Minneapolis, MN 55432

United States

Phone: 763-514-4000

Fax:

ts, such as the Complete SE Vascular Stent and the Assurant Cobalt Iliac Stent. Customers: The primary medical specialists who use the company’s Endovascular products include interventional radiologists, vascular surgeons, cardiac surgeons, and interventional cardiologists. Competition: The company’s primary competitors in the Endovascular business are Cook, Inc.; W. L. Gore & Associates, Inc.; Endologix, Inc.; TriVascular Technologies, Inc.; Lombard Medical, Inc.; Abbott; Boston Scientific; C.R. Bard, Inc.; and Johnson & Johnson, Inc. (Johnson & Johnson). Restorative Therapies Group segment This segment includes Spine, Neuromodulation, and Surgical Technologies. Spine The company’s Spine business develops, manufactures, and markets a line of medical devices and implants used in the treatment of the spine and musculoskeletal system. Its products and therapies treat various conditions affecting the spine, including degenerative disc disease, spinal deformity, spinal tumors, fractures of the spine, and stenosis. The company’s Spine business also provides biologic solutions for the orthopedic and dental markets. The company offers various lines of devices, including a range of internal spinal stabilization devices, instruments, and biomaterials used in the treatment of spinal conditions. Its Spine products are used in spinal fusion of both the thoracolumbar region, referring to the mid to lower vertebrae, and cervical region, or upper spine and neck vertebrae. Products used to treat spinal conditions include rods, pedicle screws, hooks, plates, balloons, cement, and interbody devices, as well as biologics products, primarily bone growth substitutes, including bone graft extenders and structural allografts, such as dowels and wedges. In concert with the company’s Surgical Technologies business, it offers navigation, neuromonitoring, and power technologies designed for spine procedures. The following are the principal products offered by the company’s Spine business: Thoracolumbar Products: Products used to treat conditions in this region of the spine include the CD HORIZON SOLERA and LEGACY Systems, the TSRH 3Dx System, and the T2 Altitude System. In addition, the company offers various products that facilitate less invasive thoracolumbar surgeries, including the CD HORIZON SOLERA SEXTANT and LONGITUDE Percutaneous Fixation Systems, the Direct Lateral Access System and corresponding CLYDESDALE Interbody Implant, Xpander II Balloon Kyphoplasty product for vertebral compression fractures, and the METRx System. Other products include AMT interbody implants, Powerease powered surgical instruments, and the NIM-ECLIPSE Spinal System. Cervical Products: Products used to treat conditions in this region of the spine include the ATLANTIS VISION ELITE Anterior Cervical Plate System, the VERTEX SELECT Reconstruction System, and the PRESTIGE and BRYAN Cervical Artificial Discs. China Kanghui Holdings (Kanghui): Kanghui has a portfolio of trauma and spine products focused on the improving value segment in China and other emerging markets, and is beginning to expand into large-joint reconstruction. Biologics Products: Products in the company’s Biologics platform include INFUSE Bone Graft (InductOs in the European Union), which contains a recombinant human bone morphogenetic protein, rhBMP-2, for certain spinal, trauma, and oral maxillofacial applications, Demineralized Bone Matrix products, including MagniFuse, Grafton/Grafton Plus, and PROGENIX, and the MASTERGRAFT family of synthetic bone graft products – Matrix, Putty, and Granules. Customers: The primary medical specialists who use the company’s Spine products are spinal surgeons, neurosurgeons, orthopedic surgeons, and interventional radiologists. Competition: Competitors in this business include DePuySynthes, a Johnson & Johnson Company; Stryker Corporation (Stryker); NuVasive, Inc.; Globus Medical, Inc.; Zimmer Holdings, Inc. (Zimmer); Alphatec Holdings, Inc.; K2M Group Holdings, Inc.; LDR Holding Corporation; Orthofix International N.V.; and Biomet, Inc. Neuromodulation The company’s Neuromodulation business includes implantable neurostim

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $62.71 USD +0.30

MDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $43.09 USD +0.13
Allergan Inc/United States $170.43 USD -0.71
Astellas Pharma Inc ¥1,413 JPY +8.50
Baxter International Inc $76.87 USD +0.76
Covidien PLC $88.89 USD +0.36
View Industry Companies
 

Industry Analysis

MDT

Industry Average

Valuation MDT Industry Range
Price/Earnings 20.6x
Price/Sales 3.7x
Price/Book 3.2x
Price/Cash Flow 18.2x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC INC, please visit www.medtronic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.